Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation - sprookjes - yvandenbroek - TriplyDB

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

http://www.wikidata.org/entity/Q34096483

about

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals Extracellular vesicles from infected cells: potential for direct pathogenesis Animal models for the study of HCV Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization Viral quasispecies evolution Neutralizing antibody response to hepatitis C virus Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection.Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.Evidence that hepatitis C virus genome partly controls infection outcome.Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections.Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks.In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.Broadly neutralizing antibodies abrogate established hepatitis C virus infection Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells Hepatitis C virus infection: establishment of chronicity and liver disease progression Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host Neutralizing antibodies and pathogenesis of hepatitis C virus infection.Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.HIV and co-infections.Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.New perspectives for preventing hepatitis C virus liver graft infection.

P2860

Q26773321-98467E3D-311C-4BFC-B3DC-7AE4BE47B843 Q26779430-9857BC45-4135-4E02-AC4D-DFFE60ECC56B Q26797836-32DE7B32-8F5A-4A6B-B002-FE672A9AC54E Q26801759-90ECDF42-323C-4D0E-8F41-BF6A93D0C03E Q26864485-E3786784-23B7-4D02-9BB0-C4EFDC78DBED Q27013917-4F094226-7018-4EE1-BADD-D66CAAC31540 Q27027484-C4BC4DFE-7894-4945-8838-3BE9CB6B3901 Q27678252-F279F2F8-C487-4288-9014-D4DACC7160A0 Q28478310-EF86BDC9-FC03-496E-A6E8-9BA258B61859 Q28488372-9B9FD8BA-072A-4EF0-B1AE-AEB854CE4C46 Q28659586-912433EF-7FE1-42C7-B005-E52BD2E64117 Q28731355-7BA639B7-4EB8-49AE-A97B-A759EEF45895 Q30386551-64EC295B-9B5F-47FE-9CB6-E8FDDEAFA751 Q30407004-4BE1C550-E3C0-4FDF-835E-24E42D37875D Q30541733-43F9527E-86A0-40E2-B5E9-EFEFA6212320 Q33648339-F51139CF-01B8-4DF0-A8E7-29BB8F91E0A1 Q33746744-2322837A-C5EF-4335-97AE-3E5FB82541B4 Q33883727-065C0BC7-6653-4755-A71F-8ABF1875E245 Q34043387-B3B899DC-F578-4C1B-A042-AD9485C48396 Q34093760-8D46AF66-2B21-4C97-B945-E8F6970FC69C Q34693362-892B0929-B615-46F0-A4FC-B810F04FE85B Q34806845-82CF9DA7-8AC1-49D1-8BF0-67DE2A3253FA Q34816677-04E3FE2E-5611-4148-B6DE-38E8E6B85228 Q35032263-E34F90F9-B9CF-42F2-AB29-38EBC3C824E5 Q35135565-FA4F0D04-FCD9-4C38-97E2-430A11DE7FD5 Q35153978-83B5E812-BB54-41EB-A192-C391775151BA Q35557115-2ED04598-3D0C-4054-9FDF-6A19F031A5FD Q35685409-D560C8FC-ED30-4498-B974-7936B9250695 Q35695028-B7144700-8379-4524-853B-AA37E375898B Q35728873-7FC2147F-C0BE-488E-ACC6-DB12C1D0E816 Q35847032-805112E8-8D49-46BD-8875-FA04224DCDF1 Q36318779-D1B0290B-4C2B-4FF1-8BC9-1DDF10AA010D Q36363320-00E1399F-523E-43CF-A452-6B74E2FA1895 Q36363966-1EA37518-FD27-407A-A927-7577772B0C45 Q36395837-67AEF319-B263-4A35-B26A-48F510BE5D8F Q36745425-82CEFBDE-784E-4D20-A0B3-2CBC753EC99E Q36970184-1E17EFB2-547A-4EF3-9CD8-C679D327C1C1 Q36990362-52F15F08-BFFB-4D44-9FA9-2E1525CC4C79 Q37015738-D63243CA-3E20-4A33-8E0B-E85EB213EB2C Q37015805-17F420DC-92F2-47E9-8AB9-AD7F62D11DB8

P2860

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

http://www.wikidata.org/entity/Q34096483

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Viral entry and escape from an ...... ction in liver transplantation

@ast

Viral entry and escape from an ...... ction in liver transplantation

@en

Viral entry and escape from an ...... ction in liver transplantation

@nl

type

label

Viral entry and escape from an ...... ction in liver transplantation

@ast

Viral entry and escape from an ...... ction in liver transplantation

@en

Viral entry and escape from an ...... ction in liver transplantation

@nl

prefLabel

Viral entry and escape from an ...... ction in liver transplantation

@ast

Viral entry and escape from an ...... ction in liver transplantation

@en

Viral entry and escape from an ...... ction in liver transplantation

@nl

P1433

Q34096483-C245E186-A258-4F11-A93B-A8A035E62B69

P1476

Q34096483-E27B5FAA-788B-42E4-8259-5A0A8FA5BEEC

P2093

Q34096483-0158C695-29F2-432C-BC0B-224DD2452A37

Q34096483-2E33BE4D-1330-4297-BBAB-CF942C3F31D9

Q34096483-475EA9E6-C529-49AA-BA8B-3A5B40F4C438

Q34096483-56808825-F6FB-4DA2-A5B5-F45143244212

Q34096483-93039705-E605-4D73-93E5-6218190CDD97

Q34096483-9FAB0687-D13E-4E59-B8DE-E51B76A4355D

Q34096483-A7B5C1F1-ED8F-41F5-99E6-B8911D3F36B3

Q34096483-C18F0C39-F2FD-40F1-BBE5-2AE15CAC3C09

Q34096483-ED096214-094B-47C0-9458-4D38E37707DE

Q34096483-EF81082C-686A-4B23-831C-79C58349A0F5

P2860

Q34096483-008AF214-928F-453E-AFA2-F8E6BC594234

Q34096483-03516519-2D9A-4238-BBFC-D597157103E2

Q34096483-0DC48012-E1D2-4D2C-8302-AB48195044E1

Q34096483-1056B271-5B22-4F56-BE2B-4CBC83D88CC3

Q34096483-198196E7-9A2A-46F5-9588-5E1A27E8A341

Q34096483-1F0A3081-A029-4CC0-982C-5A85189A4945

Q34096483-28384029-FD44-4CCC-BAA8-56E956F731FA

Q34096483-2ED7A071-CA6B-4AF0-913F-67D9AE4C863C

Q34096483-2EDE5FC9-3839-4C0E-A1D8-3F96B061C96C

Q34096483-3333A2A8-DDCB-4FE0-8294-F3DC1AEEDE21

P304

Q34096483-8F057205-842D-46E0-A185-9712FF5C17FD

P31

Q34096483-6459405E-85E9-4A6D-B777-64BDF2702D32

P356

Q34096483-DDDBBE4A-BAA8-4629-875D-D4CA7EA8F577

P407

Q34096483-882A20B1-E3A5-4918-A848-56B129DAB2DC

P433

Q34096483-F8D90669-3D6F-40E8-A8E6-0B98732AA6C6

P478

Q34096483-28D73F32-BD20-43E8-8803-63952DA0FEF1

P50

Q34096483-0E1D8AD8-5DC4-422C-AAEE-F89A4070CD71

Q34096483-86173D61-292A-4C35-9C98-2E41EA518FA4

Q34096483-B99425FC-4938-4CEC-8AB0-2843670D7C86

P577

Q34096483-D011BBF7-0515-4684-A5B0-F48642AD75D9

P5875

Q34096483-60A8A2BD-D163-4FA4-A451-737D2AC7A2A3

P698

Q34096483-8EBA825F-ABFE-4D06-8497-2930BA39B5A9

P921

Q34096483-2CB2E1A8-278D-4B0C-A129-D0A93EEEB244

Q34096483-88364195-5B8A-4DFE-ACE8-544015EB3AC3

P932

Q34096483-8BA95B03-699A-4612-AE3E-9ACD4914519F

P356

P1433

Journal of Experimental Medicine

P1476

Viral entry and escape from an ...... ction in liver transplantation

@en

P2093

Arvind H Patel

http://www.w3.org/2001/XMLSchema#string

Eric Soulier

http://www.w3.org/2001/XMLSchema#string

Françoise Stoll-Keller

http://www.w3.org/2001/XMLSchema#string

Isabel Fofana

http://www.w3.org/2001/XMLSchema#string

Michel Doffoël

http://www.w3.org/2001/XMLSchema#string

Patric Carolla

http://www.w3.org/2001/XMLSchema#string

Patrick Pessaux

http://www.w3.org/2001/XMLSchema#string

Philippe Wolf

http://www.w3.org/2001/XMLSchema#string

Samira Fafi-Kremer

http://www.w3.org/2001/XMLSchema#string

Thomas F Baumert

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

Robust hepatitis C virus infection in vitro.

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

P304

2019-2031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20090766

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

207

http://www.w3.org/2001/XMLSchema#string

P50

François-Loïc Cosset

Philip Meuleman

Geert Leroux-Roels

P577

2010-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45659910

http://www.w3.org/2001/XMLSchema#string

P698

20713596

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

P932

2931157

http://www.w3.org/2001/XMLSchema#string